For example, high UGT2B17 expression has recently been shown to be associated with poor prognosis in chronic lymphocytic leukaemia (CLL), partly due to enhanced local inactivation of anti-leukaemic drugs (e.g., fludarabine) within CLL cells [38,39]. The gene discussed is UGT2B17; the disease is B-cell chronic lymphocytic leukemia.